CClinicalTrials.gg
CompletedNCT05442073Updated Jul 1, 2022

Effect of Initial Empirical PEEP Setting on the Esophageal Pressure-guided PEEP Titration in ARDS

An observational study in ARDS, Human, PEEP, Occult and Esophageal and Pleural Pressure, sponsored by Peking Union Medical College Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2022-07-01.

Sponsored by Peking Union Medical College Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
18
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Esophageal manometry was used as surrogate of pleural pressure to titrate positive end-expiratory pressure (PEEP) in ARDS patients. However, Absolute values of esophageal pressure (Pes) could be affected by the PEEP setting. In moderate to severe ARDS patients, the end-expiratory Pes changed differently with PEEP adjustment. and the esophageal phenotypes could be divided into type I and type II. with Type I (ΔPes≥30%ΔPEEP)and Type II(ΔPes\<30%ΔPEEP).

02

Conditions studied

  • ARDS, Human
  • PEEP, Occult
  • Esophageal and Pleural Pressure
03

In context

Respiratory Distress Syndrome

1,596 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's enrollment of 18 is below the median of 100 across 540 observational studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

Peking Union Medical College Hospital is the lead sponsor of 1,115 studies on the registry; 463 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients all the moderate to severe ARDS with P/F\<200 no contraindication to esophageal catheter

Inclusion criteria

  • aged over 18 all the moderate to severe ARDS patients invasive mechanical ventilation

Exclusion criteria

Exclusion Criteria:

  • aged\<18 contraindication to esophageal catheter
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
18 participants (actual)
Target follow-up
28 Days
Patient registry
Yes

Groups and cohorts

  • Type I: ΔPes≥30%ΔPEEP

    Other: PEEP adjustment

  • Type II: ΔPes<30%ΔPEEP

    Other: PEEP adjustment

Interventions

  • OtherPEEP adjustment

    adjusting PEEP about 3-5cmH2O (increase or decrease)

06

What researchers measure

Primary outcomes

  1. the changes of esophageal pressure during the PEEP titration

    Time frame: March 1st to May 31st, 2022

07

Study locations

1 site
  • Peking Union Medical College Hospital
    Beijing, Beijing 100730, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05442073
Lead sponsor
Peking Union Medical College Hospital
Responsible party
Sponsor
First posted
Jul 1, 2022
Start date
Mar 1, 2022
Primary completion
May 31, 2022
Completion
Jun 29, 2022
Last update
Jul 1, 2022

Study contacts

Shuyang Zhang, MD
study chair · Peking Union Medical College Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion